Default company panoramic image

Arcato Laboratories

Arcato’s product, OraWax™, targets orthodontists and their patients as the first effective treatment for oral discomfort caused by braces

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Greensboro, NC, USA
  • Currency USD
  • Founded January 2011
  • Employees 1
  • Website

Company Summary

Arcato’s first product, OraWax™, will target orthodontists and their patients as the first effective treatment for oral discomfort caused by orthodontic appliances (braces). OraWax™ will relieve the irritation and discomfort experienced by the approximately two million new orthodontics patients each year. Current products are ineffective but medicated OraWax™ has demonstrated a significant reduction in braces pain during clinical trials.


  • Default avatar
    Robert Michael Jordan

    Arcato is led by Bob Jordan who serves as Chief Executive Officer. For the past 25 years, Bob has managed numerous companies and startups from a wide range of industries. Bob has a proven background in corporate turnarounds, strategic planning, and leadership development.

  • Default avatar
    Matt Loecke
    Chief Marketing Officer

    Arcato’s sales and marketing efforts will be led by Matt Loecke, as Arcato’s Chief Marketing Officer. Matt is a 15-year veteran of sales and marketing leadership, first serving as Vice President of Sales for a Chapel Hill-based media firm leading a field sales force of 30 regional sales managers and over 600 sales personnel. Currently, Matt serves as a consultant to companies in an array of industries including animal health and pharmaceuticals

  • Default avatar
    Michael Jay
    Chief Scientific Officer

    Co-founder of Arcato and co-inventor of OraWax™ is Michael Jay, Ph.D., who serves as Chief Scientific Officer. Dr. Jay is a professor and distinguished chair of the division of molecular pharmaceutics at the University of North Carolina at Chapel Hill, and is an expert on drug delivery and formulations.